Fiera Capital (Canada)
TEVA icon

Fiera Capital (Canada)’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Fiera Capital (Canada)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-155,515
Closed -$2.74M – 676
2017
Q3 		$2.74M Sell
155,515
-33,459
-18% -$753K 0.01% 350
2017
Q2 		$6.28M Buy
188,974
+4,463
+2% +$138K 0.03% 286
2017
Q1 		$5.92M Buy
184,511
+7,641
+4% +$261K 0.03% 284
2016
Q4 		$6.41M Buy
176,870
+29,095
+20% +$1.16M 0.04% 285
2016
Q3 		$6.8M Sell
147,775
-13,140
-8% -$686K 0.04% 280
2016
Q2 		$8.08M Buy
160,915
+33,427
+26% +$1.78M 0.05% 255
2016
Q1 		$6.82M Buy
127,488
+15,654
+14% +$918K 0.05% 143
2015
Q4 		$7.34M Buy
111,834
+41
+0% +$2.53K 0.06% 158
2015
Q3 		$6.31M Sell
111,793
-5,345
-5% -$347K 0.05% 167
2015
Q2 		$6.92M Sell
117,138
-4,419
-4% -$273K 0.04% 175
2015
Q1 		$7.57M Buy
121,557
+9,668
+9% +$562K 0.06% 169
2014
Q4 		$6.43M Buy
111,889
+2,011
+2% +$112K 0.05% 168
2014
Q3 		$5.91M Sell
109,878
-7,888
-7% -$418K 0.04% 193
2014
Q2 		$6.17M Buy
117,766
+22,614
+24% +$1.16M 0.03% 206
2014
Q1 		$5.03M Buy
95,152
+6,545
+7% +$302K 0.04% 203
2013
Q4 		$3.55M Buy
+88,607
New +$3.49M 0.03% 264

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Fiera Capital (Canada)'s TEVA Position: Q4 2017 in Review

Fiera Capital (Canada) sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2017, closing a stake of 155,515 shares — an estimated $2.74M sold.

Fiera Capital (Canada) first reported a position in TEVA in Q4 2013 and held it in 16 quarters. The position peaked at $8.08M in Q2 2016. 508 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Fiera Capital (Canada) reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2017 after selling out during the quarter.
  • Fiera Capital (Canada) sold 155,515 Teva Pharmaceutical Industries Limited shares in Q4 2017, an estimated $2.74M.
  • Fiera Capital (Canada) first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 16 quarters.
  • Fiera Capital (Canada)'s Teva Pharmaceutical Industries Limited position peaked at $8.08M in Q2 2016.
  • 508 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2017.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2017, filed 9 Feb 2018.